Soilbuild Reit's sponsor signs term sheet for possible transaction of interests
THE non-executive director of Soilbuild Business Space Reit's manager, Lim Chap Huat, has entered into a non-binding term sheet in relation to a possible transaction involving his interests, and those of his three sons Lim Han Feng, Lim Han Qin and Lim Han Ren in the real estate investment trust (Reit).
In a bourse filing on Friday, the Reit's manager said the signing of the term sheet may or may not lead to a transaction for the Reit's units.
It emphasised that there is no certainty or assurance that any transaction will occur.
The Lims - who are sponsors of Soilbuild Reit - jointly hold a 30 per cent stake in the Reit as at Aug 31, a Soilbuild Reit spokesperson told The Business Times on Friday afternoon.
Mr Lim Chap Huat, who is also the chairman of Soilbuild Group Holdings holds a 9.2 per cent stake, while Soilbuild Group directors Mr Lim Han Feng, Mr Lim Han Qin and Mr Lim Han Ren own 6.9 per cent each, the spokesperson said.
The Reit manager said it will release further announcements if and when there are any material developments which warrant disclosure.
A NEWSLETTER FOR YOU
Property Insights
Get an exclusive analysis of real estate and property news in Singapore and beyond.
The manager requested a trading halt on Tuesday at 3.36pm, which it lifted before the market opened on Friday. Units of Soilbuild Business Space Reit were trading at 48 Singapore cents as at 9.57am on Friday, up 2.5 cents or 5.5 per cent. (see amendment note)
Amendment note: A previous version of this article stated that units of Soilbuild Reit were trading on Thursday. Trading in the counter was in fact halted on Tuesday, with the halt lifted early on Friday.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance